PuSH - Publikationsserver des Helmholtz Zentrums München

Redhu, D.* ; Kumari, V. ; Franke, K.* ; Hartmann, K.* ; Worm, M.* ; Babina, M.*

TNFα counters skin inflammation by restraining mast cell-dependent TSLP production.

J. Allergy Clin. Immunol. 156, 150-158 (2025)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: TNFα is an important proinflammatory cytokine, but its neutralization in the management of inflammatory skin disorders like psoriasis may trigger eczematous skin lesions as an adverse reaction. OBJECTIVES: This study aimed to elucidate whether TNF-α may protect from skin inflammation and to identify in detail the underlying mechanisms. METHODS: Wildtype, TNF-α-deficient, TSLPR-deficient, mast cell (MC)-deficient, TNF-α-TSLPR-double-deficient and TNF-α-MC-double-deficient mice were subjected to a skin inflammation model and inspected by physical, clinical, histological, immunohistochemical and bioanalytical techniques. RESULTS: TNFα deficiency promoted skin inflammation. This was accompanied by MC hyperplasia and potent TSLP production in lesional skin and serum of TNFα deficient mice. Specifically, MCs were found to be responsible for inducing high levels of TSLP in the epidermis, compromising barrier function and initiating inflammation. In contrast, the production of immunoglobulins, including IgE, was reduced in mice lacking TNFα. CONCLUSIONS: TNFα restrains MC-dependent TSLP production and the onset of eczema.
Impact Factor
Scopus SNIP
Altmetric
11.200
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Eczema ; Mast Cells ; Thymic Stromal Lymphopoietin ; Tumor Necrosis Factor α; Tumor-necrosis-factor; Allergic Immune-response; Human Epithelial-cells; Atopic-dermatitis; Lesions; Mice; Keratinocytes; Sensitization; Activation; Infliximab
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0091-6749
e-ISSN 1097-6825
Quellenangaben Band: 156, Heft: 1, Seiten: 150-158 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Amsterdam [u.a.]
Begutachtungsstatus Peer reviewed
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505400-001
Förderungen Deutsche Forschungsgemeinschaft (German Research Foundation)
Scopus ID 105003294565
PubMed ID 40189158
Erfassungsdatum 2025-05-10